Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05971199
What this trial is testing

Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 27
Not applicableLooking for participantsNCT06561399
What this trial is testing

Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Fujian Provincial Hospital 28
Not applicableStudy completedNCT05053412
What this trial is testing

HELIO Liver Test Performance Study in China (HEPATIC)

Who this might be right for
Hepatocellular Carcinoma and Liver Disease
Helio Genomics 1,556
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Not applicableUnknownNCT05242237
What this trial is testing

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

Who this might be right for
Hepatocellular CarcinomaCirculating Tumor CellWhole Genome Sequencing
The Second Affiliated Hospital of Chongqing Medical University 300
Not applicableStudy completedNCT02003339
What this trial is testing

Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium

Who this might be right for
Hepatocellular Carcinoma
Center Eugene Marquis 25
Not applicableUnknownNCT03356236
What this trial is testing

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Who this might be right for
Hepatocarcinoma
Yue Han 828
Not applicableStudy completedNCT04844112
What this trial is testing

CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 139
Post-approval studies (Phase 4)Not Yet RecruitingNCT07358975
What this trial is testing

Prediction of Complications in Hepatic Tumors

Who this might be right for
Hepatic Tumors
Rigshospitalet, Denmark 192
Not applicableNot Yet RecruitingNCT06994130
What this trial is testing

Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

Who this might be right for
Hepatic Cancer
ImCare Biotech 1,392
Testing effectiveness (Phase 2)Study completedNCT01334112
What this trial is testing

Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131501
What this trial is testing

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapyPreoperative+2 more
The First Affiliated Hospital with Nanjing Medical University 48
Not applicableUnknownNCT04471272
What this trial is testing

RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes

Who this might be right for
Radiofrequency AblationCarcinoma, Hepatocellular
Seoul National University Hospital 120
Not applicableStudy completedNCT06720675
What this trial is testing

Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

Who this might be right for
Liver CarcinomaLiver TransplantTumor Recurrence+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 237
Not applicableStudy completedNCT07368530
What this trial is testing

Using Machine Learning to Identify Responders to TACE or HAIC for uHCC

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 3,000
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Testing effectiveness (Phase 2)Study completedNCT00790218
What this trial is testing

A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Can-Fite BioPharma 19
Post-approval studies (Phase 4)Study completedNCT04288323
What this trial is testing

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

Who this might be right for
Liver CancerLiver CirrhosesLiver Carcinoma
University of California, San Diego 79
Testing effectiveness (Phase 2)Ended earlyNCT02575339
What this trial is testing

MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerHCC
Kathy Miller 11
Post-approval studies (Phase 4)UnknownNCT00555334
What this trial is testing

Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 200
Next Page